Close menu




March 18th, 2026 | 07:10 CET

Gold at USD 10,000? Analysts See Over 500% Upside Potential for Desert Gold

  • Mining
  • Gold
  • Africa
  • Commodities
  • Investments
Photo credits: pixabay

Will we see the price of gold reaching USD 10,000 per ounce in a few years? After JPMorgan CEO Jamie Dimon caused a stir last year with such a forecast, other prominent experts are now following suit. Among others, Ed Yardeni, President of Yardeni Research, Peter Schiff, Chief Strategist at Euro Pacific Asset Management, and Jefferies strategist Chris Wood also believe five-figure prices for the precious metal are possible in the coming years. Gold thus continues to promise investors glittering returns. Desert Gold could become a top performer in your portfolio as early as this year. Analysts see over 500% upside potential.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: DESERT GOLD VENTURES INC | CA25039N4084 | TSXV: DAU , OTCQB: DAUGF

Table of contents:


    Multiple Catalysts

    Regardless of the potential USD 10,000 per troy ounce, investors could soon experience golden times with Desert Gold. The company is among the most exciting gold stocks and could really take off in 2026. That is because there are several catalysts: the transition to production, significant exploration potential, and fresh capital in the coffers. Most recently, CEO Jared Scharf emphasized in an interview with Lyndsay Malchuk of the International Investment Forum that the recently completed financing of over CAD 7.2 million will allow the company to accelerate progress on multiple fronts. The funds are intended to bring the first phase of a gravity plant at the Mali project online. This could happen as early as June. Desert Gold is also using the funds to finance further drilling in Mali as well as initial work on the project in Côte d'Ivoire.

    Fast, Cost-Effective Entry into Production

    The strategy in Mali is particularly interesting. Scharf made it clear that the economic assessment to date captures only a small portion of the total potential. The PEA primarily refers to near-surface oxide mineralization and thus only to about 10% of the currently known resource of approximately 1.3 million ounces. Even at a gold price of just USD 3,000 per ounce, the internal rate of return (IRR) of the initial PEA stands at 57%. The net present value (NPV 10%) after taxes is over USD 61 million. This suggests potential upside relative to the current valuation. From management's perspective, this represents a rapid, cost-effective entry into production. The idea behind it is compelling. With a comparatively straightforward start to production, the aim is to generate cash flows to finance further exploration without unduly diluting shareholders. Furthermore, the start of production could attract new, financially strong partners to jointly ramp up production more quickly. It is precisely this combination of short-term monetization and long-term leverage from additional discoveries that makes the investment case particularly compelling.

    Tiegba Gold Project Could Deliver Positive Upside

    The company's second pillar in Côte d'Ivoire offers additional upside potential. There, Scharf sees the Tiegba Gold project as a potential surprise factor for the market. The area lies on a promising trend, covers around 300 sq km, and contains a geochemical anomaly several kilometers long that was previously delineated but never systematically drilled. Desert Gold has confirmed the anomaly and plans to test it specifically following a drone survey. This opens up a second opportunity for a significant new discovery alongside the advanced Mali project. It is precisely this combination of financing security, operational progress, production prospects, and additional exploration leverage that could make Desert Gold THE gold stock of 2026.

    https://youtu.be/dd2rbdGuZDo?si=XHECivSVJKODatxg

    The Stock Has Finally Broken Out

    The stock's price performance over the past few weeks shows that the story now makes perfect sense. The stock has jumped from EUR 0.05 to EUR 0.08. However, this has merely initiated the revaluation. After all, the stock was at this level back in 2022. At that time, the gold price was quite different, and the project in Côte d'Ivoire did not yet exist. Analysts at GBC Research continue to recommend Desert Gold shares as a "Buy". They estimate the stock’s fair value at EUR 0.59, implying significant upside potential.


    Conclusion: Over 500% Upside Potential and Takeover Speculation

    From the perspective of GBC analysts, Desert Gold shares thus have over 500% upside potential. As described, there are good reasons to believe the stock can reach this level. And then there is the takeover potential. With reserves of 1.3 million ounces and further potential, the company has the necessary scale to be attractive to a larger producer.

    Desert Gold's stock has only just begun its revaluation. Source: LSEG

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST

    AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly

    • Biotechnology
    • Pharma
    • Biotech
    • AI
    • Investments

    Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.

    Read

    Commented by Fabian Lorenz on June 29th, 2026 | 07:15 CEST

    Gold at USD 6,000! Analysts Turn Bullish! Lahontan Gold Stock Belongs in the Portfolio

    • Mining
    • Gold
    • Silver
    • Commodities
    • Nevada
    • geopolitics

    Will the falling oil price fuel a new rally in gold? In recent weeks, inflation fears and the associated concerns about rising interest rates have been among the key headwinds for precious metals. With the expected easing of geopolitical tensions in the Iran conflict, this pressure is now diminishing. Lower energy prices could ease inflation expectations, thereby reducing the likelihood of further rate hikes. Gold has recently defended the USD 4,000 per ounce level and even briefly traded above USD 4,300 on Wednesday. Gold expert Markus Bußler remains bullish, a view that should also support renewed strength in gold equities. Lahontan Gold is in an exciting phase. The company is currently transitioning from explorer to producer—not just anywhere, but in one of the world's most attractive gold mining regions. While preparations for mine construction are underway, the company continues to report positive drill results.

    Read

    Commented by André Will-Laudien on June 29th, 2026 | 07:10 CEST

    Gold, Defense, Aerospace: Sector Rotation in Full Swing – SpaceX, OHB, Desert Gold, Rheinmetall, and TKMS

    • Mining
    • Gold
    • Silver
    • Commodities
    • Africa
    • Defense
    • Steel
    • Space

    Stock markets remain surprisingly resilient as the end of June approaches, but the glossy surface is starting to fade in certain segments. The bull market in aerospace is losing steam, and in the defense sector, after many months of gains, profit-taking is now becoming noticeable. As a result, valuations are gradually re-aligning with fundamentals. For rational investors, market hype is difficult to reconcile with, but one thing remains clear: stocks that become excessively overvalued tend to correct sharply when expectations are pushed to extreme levels without sufficient justification. Just as with Elon Musk's inflated initial valuation, the exit bell has likely rung quite loudly for Rheinmetall as well. In the fall, analysts had been outbidding each other with price targets around EUR 2,200; now they are painfully backtracking. Price declines of 20% in just a few trading hours for the defence sector star, and a 30% drop from its peak for SpaceX. But there are other hot candidates worth a closer look. OHB is drawing attention following a significant capital increase, while TKMS has secured a major naval contract. These developments are actively reshaping market dynamics—we break down what it means in detail.

    Read